M&A

MA Financial Group has added Hyperdome Town Centre to its real estate portfolio, acquiring the South-East Queensland shopping complex from QIC for $678.7 million.

The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.

The Foreign Investment Review Board has extended the deadline for ruling on Cosette's proposed $672 million takeover of Mayne Pharma.

Hong Kong-based Link REIT has made a play to acquire three of five Lendlease shopping centre assets that comprise a $2.9 billion property fund that are being sold down amid a slew of redemption requests.

Ashurst has announced plans to merge with US law firm Perkins Coie, creating a powerhouse firm with 3,000 lawyers across 23 countries with ambitions to lead the way on AI.

The Takeovers Panel has agreed to hear Mayne Pharma's latest dispute with Cosette over the US drug maker's attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.

Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.

MinterEllison has lured a leading corporate law partner away from King & Wood Mallesons to lead the firm's private equity practice.

Cosette plans to appeal a ruling that rejected its bid to terminate an agreement to merge with Mayne Pharma, as the US drug company also refuses to agree to conditions needed to win Foreign Investment Review Board approval for the tie-up.

AGL has agreed to sell the lion's share of its equity stake in Tilt Renewables to the Queensland Investment Corporation and Australia's sovereign wealth fund for $750 million.